Current investments

We have one or more companies open for investments. Please login or create an account to learn more and invest.

Completed investments

PharmNovo

PharmNovo develops drugs for chronic pain based on a new type of selective delta opioids. The main candidate PN6047 shows promising results on effective pain relief without negative side effects.

Read more

Cavis Technologies

Cavis Technologies has developed a combined guidewire/catheter, Wirecath®, for diagnosis of people with coronary heart disease. Wirecath® is expected to provide important clinical benefits.

Read more

Elypta

Elypta has developed a new method for early cancer diagnosis. Liquid Biopsy is a rapidly growing field that is expected to be of great importance for cancer diagnosis.

Read more

Predicare

Predicare is the company behind the system RETTS©, used by 95% of Sweden’s hospitals and ambulances. RETTS© daily helps healthcare professionals to make the right decisions in emergency situations.

Exits

Learning to Sleep

Learning to Sleep is a digital sleep clinic. The company offers an evidence-based treatment that uniquely combines support from a sleep coach with digital aids.

Read more

Cartana

Cartana’s patent-applied research tool revolutionizes the possibility of analyzing tissue samples, providing pharmaceutical companies with important information in their quest for new treatments.

Read more

Inhalation Sciences

Inhalation Science’s technology is used by leading players in the chemical and pharmaceutical sectors to study how airborne particles affect the human body.

Read more

Attana

With Attana’s patented technology, pharmaceutical companies can evaluate, in an early development stage, how drug candidates impact the body and can identify the risk of side effects.

Read more